Looking for the PDF version of your favorite article? Please see the attachments below.

   

Dr. Gerald D. Klee of Timonium died on March 3, 2013, five days after breaking his hip.

Pictures coming soon!

The Maryland Psychiatric Society hosted a conference at Sheppard Pratt on March 23, 2013 entitled “Psychopharmacology - Updates, Advances & New Information”, for which I was asked to give a presentation about new developments concerning atypical antipsychotic agents. So I pondered. It had been a while since the newest triad of atypicals (asenapine, iloperidone, and lurasidone, in generic alphabetical order) made their appearance, and long-acting injectable paliperidone isn’t news anymore. I’d heard tha

Since 1994, all diplomates of the American Board of Psychiatry and Neurology have received time-limited 10-year certificates. The rationale proposed for this change was to ensure that physicians were maintaining a lifelong education in their specialty, and demonstrating that they were practicing with competency. Individuals who were board-certified prior to October, 1994, need not participate in Maintenance of Certification (MOC), but may elect to do so.

Now that we are coding psychotherapy as an “add on” to an E&M code, it is worthwhile to review how it impacts the doctor-patient relationship. I would argue that as psychiatrists who are also psychotherapists, we modify our relationship to the patient in a way that allows psychotherapy to happen. This is most clearly true for longer-term psychodynamic psychotherapy, where much of the change requires a deep appreciation of the complexity of this relationship. In fact, the therapeutic relationship may become the p

Confidentiality in medical treatment is a venerable, even archaic, value. It stretches back through English Common Law to the dawn of medical ethics in the Hippocratic Oath What I may see or hear in the course of the treatment  . . . I will keep to myself, holding such things shameful to be spoken about.